Upper extremity dysfunction after dotter procedures via the wrist

Transradial percutaneous coronary intervention is rapidly becoming the gold standard especially in primary PCI,with increased use of antithrombotic agents, where most benefit of the radial approach can be expected such as reduced major bleeding and mortality. However there is very limited research available looking at the consequences of transradial access for upper extremity function.
The main objective of this study is to provide insight in the morbidity with regards to the upper extremity surrounding the radial access route in percutaneous coronary interventions. Secondary objectives are to provide insight in the consequences for functional status, factors influencing and financial costs of this morbidity, to identify subject who might benefit from early referral and treatment of this morbidity and to generate hypotheses for further clinical research into this matter.

Approximately 20% of the patients will experience complications or upper extremity dysfunction after PCI

After intervention patients will undergo follow-up after 24 hours, two weeks, one and six months.

All patients will, after baseline examinations be treated with the intent of using the radial artery for access.